EBS - CIK 0001367644
Emergent BioSolutions Inc. has filed 997 documents with the SEC between 2014 and 2026. The most frequent type is insider trade (516 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider trade | 4 | 2026-05-04 | 2026-04-30 |
| Insider trade | 4 | 2026-05-04 | 2026-04-30 |
| Insider trade | 4 | 2026-05-04 | 2026-04-30 |
| Insider trade | 4 | 2026-05-04 | 2026-04-30 |
| Insider trade | 4 | 2026-05-04 | 2026-04-30 |
| Insider trade | 4 | 2026-05-04 | 2026-04-30 |
| Insider trade | 4 | 2026-05-04 | 2026-04-30 |
| Insider trade | 4 | 2026-05-04 | 2026-04-30 |
| Insider trade | 4 | 2026-05-04 | 2026-04-30 |
| Insider trade | 4 | 2026-05-01 | 2026-04-29 |
| Insider trade | 4 | 2026-05-01 | 2026-04-29 |
| Insider trade | 4 | 2026-05-01 | 2026-04-29 |
| Insider trade | 4 | 2026-05-01 | 2026-04-29 |
| Insider sale notice | 144 | 2026-05-01 | - |
| Insider sale notice | 144 | 2026-05-01 | - |
| Insider sale notice | 144 | 2026-05-01 | - |
| Insider trade | 4 | 2026-05-01 | 2026-04-29 |
| Quarterly report | 10-Q | 2026-05-01 | 2026-03-31 |
| Insider trade | 4 | 2026-05-01 | 2026-04-29 |
| Insider trade | 4 | 2026-05-01 | 2026-04-29 |
| Insider sale notice | 144 | 2026-04-30 | - |
| Employee stock plan | S-8 | 2026-04-30 | - |
| Major company event | 8-K | 2026-04-30 | 2026-04-30 |
| Major company event | 8-K | 2026-04-30 | 2026-04-29 |
| SCHEDULE 13G | - | 2026-04-29 | - |
| Proxy materials | DEFA14A | 2026-04-28 | - |
| Proxy materials | DEFA14A | 2026-04-27 | - |
| Proxy materials | DEFA14A | 2026-04-22 | - |
| Major company event | 8-K | 2026-04-17 | 2026-04-16 |
| Proxy materials | DEFA14A | 2026-04-16 | - |
| Proxy materials | DEFA14A | 2026-04-16 | - |
| SCHEDULE 13G | - | 2026-04-09 | - |
| Insider trade | 4 | 2026-04-03 | 2026-04-01 |
| Insider sale notice | 144 | 2026-04-01 | - |
| SCHEDULE 13G/A | - | 2026-03-26 | - |
| Annual report to shareholders | ARS | 2026-03-20 | 2025-12-31 |
| Proxy materials | DEFA14A | 2026-03-20 | - |
| Proxy statement | DEF 14A | 2026-03-20 | 2025-12-31 |
| Insider trade | 4 | 2026-03-06 | 2025-05-07 |
| Insider trade | 4 | 2026-03-05 | 2026-03-03 |
| Insider trade | 4 | 2026-03-05 | 2026-03-03 |
| Insider trade | 4 | 2026-03-05 | 2026-03-03 |
| Insider trade | 4 | 2026-03-05 | 2026-03-03 |
| Insider trade | 4 | 2026-03-05 | 2026-03-03 |
| Insider trade | 4 | 2026-03-05 | 2026-03-03 |
| Insider trade | 4 | 2026-03-05 | 2026-03-03 |
| Insider trade | 4 | 2026-03-05 | 2026-03-03 |
| New insider ownership | 3 | 2026-03-05 | 2026-03-01 |
| Insider trade | 4 | 2026-03-03 | 2026-03-01 |
| Insider trade | 4 | 2026-03-03 | 2026-03-01 |